Background/Aims: Unlike other organs, which only have one set of capillary network, the renal microvasculature consists of two sets of capillary network series connected by efferent arterioles. Angiotensin II constricts the efferent glomerular artery. Hence, renal tumor blood flow (BF) distribution may be different from tumors in other organs. This study aims to investigate the effects of angiotensin II on the hemodynamics of intrarenal VX2 tumors using perfusion computed tomography(CT). Methods: Twenty-four male New Zealand white rabbits were randomly divided into three groups: groups A (blank controls), group B (negative controls), and group C (angiotensin II-treated animals). Group B and C were established to the model of intrarenal VX2 tumors. Furthermore, perfusion CT of the kidney was performed in each group. Prior to perfusion CT scan in group C, the mean arterial blood was elevated to 150-160 mmHg by angiotensin II. The BF, blood volume (BV), mean transit time (MTT), capillary permeabilitysurface area product (PS), and relative permeability-surface area product (RPS) of tumors and renal tissues were calculated. Results: Compared with normal renal cortex tissues in group A, the BF, BV and PS values of tumors in group B were significantly lower, MTT was prolonged and RPS increased. Compared with group B, only the RPS of these tumors increased from 83.23 ± 29.17% to 120.94 ± 31.84% by angiotensin II infusion. Angiotensin II significantly increased the RPS value of the renal cortex distant from the tumor (CDT) and the right renal cortex (RRC). Conclusions: Perfusion CT can accurately observe the influence of angiotensin II on normal and tumor BF in kidneys. This clarifies the effect of angiotensin II on intrarenal tumor hemodynamics.
Introduction
There are clear differences between tumor vessels and normal blood vasculature [1] [2] [3] . Normal microvasculature has a complete structure, including an endothelial cell lining, the presence of mural cells (smooth-muscle cells and pericytes) around endothelial cells, and the basement membrane enveloping both types of cells [4] . The blood vessels of tumors are dynamic, defective and leaky [5] [6] [7] [8] [9] [10] . Furthermore, tumor blood vessels are irregular in size, shape and branching pattern. Abnormalities are present in all components of the vessel wall. Tumor blood vessels manifest large endothelial cell-cell gap openings that permit the leakage of macromolecules into the interstitial space of tumor tissues [6, 7] . The basement membrane is also often thickened abnormally or absent, further enhancing the aberrant permeability of tumor blood vessels [8] . Mural cells that normally cover and stabilize the outer vessel wall can also be missing or detached, leading to a more immature vessel structure. The absence of these contractile support cells may also further increase vessel permeability and weaken control over blood flow (BF) [9, 10] .
Angiotensin has a direct stimulant action on the smooth muscle of the vascular system [11] . In the absence of these normal contractile support cells in tumor vessels, angiotensin II can selectively enhance the vascular permeability and BF of tumor tissues without increasing blood flow in normal tissues, and improve the diagnosis and treatment of tumors through the selective enhancement of drug delivery to the tumor tissue [12] [13] [14] [15] [16] [17] . Selective arterial infusion [12] [13] [14] [15] [16] or the intravenous administration [17] of angiotensin II has been investigated as a method to increase perfusion in both human [12] [13] [14] and animal experiments [15] [16] [17] in various tumors, including cancers of the liver, kidney and gallbladder.
The fundamental principle of perfusion computed tomography (CT) is based on temporal changes in tissue attenuation. After the intravenous injection of contrast material, changes in tissue attenuation indirectly reflect tissue vascularity and vascular physiology. Perfusion CT is an evolving noninvasive technique that allows for the measurement of microvascular tumor circulation and tumor angiogenesis. In vivo tumor perfusion characteristics can be evaluated by analyzing the dynamics of tissue enhancement after intravenous contrast administration [18, 19] . CT perfusion imaging can predict the early response to treatment and survival of malignant tumor patients [20, 21] .
The microvasculature of each organ is specialized in concert with the unique functions of each organ. The microvasculature of every organ has a hierarchical organization of arterioles, capillaries and venules, which have their own specialized structural and functional properties [5] . The microvasculature of the kidney consists of afferent arterioles, glomerular capillaries, efferent arterioles, capillary networks around the renal tubular, and venules [11, 22, 23] . Angiotensin II constricts the efferent glomerular artery rather than the afferent glomerular artery [11, 22, 23] . Therefore, it could be hypothesized that angiotensin II can influence normal renal tissues, and the renal tumor BF distribution may be different from tumors in other organs, which has its unique imaging findings. Perfusion CT can be used to understand this vasoactive effect. The purpose of the present study was to investigate the effects of the intravenous administration of angiotensin II on renal vascularity in normal rabbit renal tissues and rabbit intrarenal VX2 tumors by perfusion CT.
Materials and Methods

Experimental animal model
All animal protocols were approved by the Institutional Animal Care and Use Committee of the Affiliated Hospital of Hebei University (Permit Number: 2014-10). Two rabbits bearing VX2 tumors in the left femoribus internus muscle were provided by the Experimental Center of Hebei University Health Science Center (Baoding, China). Twenty-four male New Zealand white rabbits (two months old; supplied by Xinglong Laboratory Animal Farm, Beijing, China; No. 11805800000637), weighing approximately 2.9-3.2 kg, were divided into three groups using the random number a slow intravenous injection of 25% urethane, at 4 ml/kg (Shanpu, Shanghai, China). These rabbits were fixed on a bed stand on the right lateral decubitus, and the left kidney was exposed by performing a left paravertebral incision. An approximately 1.0-cm incision was established using a surgical blade. In group A (blank controls, n=8), solitary autologous perirenal adipose tissue were implanted into the left kidney incision. In group B (negative controls, n=8) and group C (angiotensin II-treated animals, n=8), solitary VX2 tumor tissue masses of 1-2 mm 3 were implanted into the left kidney incision. Then, the left kidney incision was closed by applying pressure using a sterile gelatin sponge, and rapidly spraying and coating with medical adhesive (Compont, Beijing, China), in order to prevent the biogum adhesive from entering the adjacent organs and tumor tissue overflow. After spraying saline in the wound, each layer of the dorsum was sutured. The procedure was performed under aseptic surgical conditions, and the animals were returned to their cage and fed with standard rabbit food and water ad libitum. The day of tumor inoculation was considered as day zero. The tumors were allowed to grow for 2-3 weeks, and the tumor growth was monitored by ultrasonography (Vevo 2100 Imaging System, MS201 Probe, Fujifilm VisualSonics, Toronto, Canada) every 4-5 days after implantation. Solid tumors of 1.5-2.0 cm in diameter were used in group B and group C.
Preparation prior to CT examination
A 22-gauge closed intravenous catheter (BD Intima II, Suzhou, China) was placed in a marginal ear vein to sedate the animals with urethane before being fixed on a bed stand in the supine position. The cervical region of the rabbit was shaved and disinfected with povidone iodine. Through cervical median incision, the left common carotid artery was isolated. Then, mean arterial blood pressure (MABP) was measured via a catheter inserted into the left common carotid artery, and 100 IU of heparin per kilogram of body weight was administered. The pressure in the catheter was continuously recorded using a pressure transducer (TM1412016; Taimeng, Chengdu, China), and the output was sent to the biological function experimental system (BL-420S; Taimeng, Chengdu, China). A Foley catheter was advanced into the bladder for urine drainage and urinalysis.
Blood pressure was elevated by continuous infusion of angiotensin II (Solarbio, Beijing, China) into the marginal ear vein in group C. Angiotensin II was dissolved in normal saline at a concentration of 5 µg/ml, and was infused using a peristaltic pump at 1-2 µg/kg/min (HL-2; Huxi, Shanghai, China). Changes in blood pressure were measured using the biological function experimental system.
Perfusion CT examination
At the time of imaging, the biological function the experimental system, peristaltic pump and the entire rabbit were lined into the CT scanner (Discovery CT750 HD; GE Medical Systems, Milwaukee, WI, USA). The rabbits were fixed in the supine head-first position with an abdominal compression bandage, in order to reduce artifacts caused by unnecessary respiratory movement. Tubing for the contrast material, normal saline and the peristaltic pump were attached to the ear vein catheter. First, a nonenhanced abdominal CT examination was performed to locate the renal tumor for perfusion imaging in groups A, B and C. Subsequently, perfusion CT scans were initiated for rabbits in groups A and B using a volume helical shuttle mode of acquisition (120 kV, 150 mAs; scan field of view [SFOV], large body; display field of view [DFOV], 160 mm; matrix, 512×512 pixels; detector coverage, 40.0 mm; thickness, 5.0 mm; pitch, 1.375:1.000; rotation time, 0.4 seconds; 31 passes; total exposure time, 50.44 seconds), and 5.0 mL of contrast material (Ioversol, 320 mg I/ml; Hengrui Medicine, Jiangsu, China) was injected using a high-pressure syringe (ACIST, Eden Prairie, USA) at a rate of 1.0 ml/sec. The contrast material injection was followed by 3.0 ml of saline solution at the same flow rate. Prior to the perfusion CT scan, rabbits in group C were infused with angiotensin II using a peristaltic pump. MABP was elevated to 150-160 mmHg and maintained for 5-10 minutes, in order to perform perfusion CT scans using the same previous scanning parameters.
Image post-processing
The perfusion images were reconstructed from the raw projection data onto a 512×512 pixels matrix with a section thickness of 1.25 mm before being transferred to the GE ADW4.5 workstation. The CT perfusion software (Kidney Protocol, Body Tumor Perfusion 4.0; GE Healthcare) was used for perfusion analysis. A region of interest (ROI) of 5 mm 2 was carefully demarcated to obtain the satisfactory time-density curves (TDC). These ROIs included the abdominal aorta, tumor tissue, renal cortex directly adjacent to the tumor (CAT), renal cortex distant from the tumor (CDT), and right renal cortex (RRC). The paravertebral Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry muscle (PVM) was also obtained at the same level of the tumor (Fig. 1) . The abdominal aorta was used instead of the renal artery, in order to avoid artifacts caused by unnecessary respiratory movement. Pseudo-color functional maps were obtained and various perfusion parameters were measured in the ROI. Thus, the BF, blood volume (BV), mean transit time (MTT) and capillary permeability-surface area product (PS) of the tissue could be calculated. The relative permeability-surface area product (RPS) refers to the ratio of extravascular-intravascular fluid exchange capacity to the intravascular fluid volume. RPS was calculated using the following formula: PS/ BF×100%; where BF and PS represents the blood flow and capillary permeability-surface area product, respectively.
Pathological examination
After the CT scan, pathological anatomy was performed to observe the presence of pleural effusion, abdominal effusion, and the metastasis of the lung, abdominal and pelvic organs. The kidney was taken and hematoxylin and eosin (H&E) staining was performed. Then, the relationship between tumor tissues and the surrounding renal tissue, renal sinus and renal capsule was observed.
Statistical analysis
All data were expressed as mean ± standard deviation (SD). All statistical analyses were carried out using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA). One-way ANOVA was used to analyze the statistical differences of the measured values of various perfusion parameters of the tumor, CAT, CDT and PVM among the different groups. The LSD-t method was used to adjust for multiple comparisons. Two-tailed student's t-test was used to compare perfusion parameters between the cortex adjacent to the tumor and the cortex distant from the tumor in groups B and C. Statistical significance was assigned at the 5% level.
Results
Inclusion vs exclusion criteria of intrarenal VX2 tumors
Inclusion criteria: (1) The maximum diameter of tumor is 1.5-2.0 cm by ultrasonography or perfusion CT observation, without obvious necrotic areas. The calcification area is no more than 40% of the tumor's maximum cross-section. (2) The main body of the tumor is within the outline of the kidney, which can slightly protrude from the outline of the kidney, and the renal capsule is intact. (3) The perirenal adipose space around the tumor can be observed by perfusion CT imaging, and there is no obvious thickening in the adjacent abdominal wall. (4) Urinalysis revealed no blood urine.
Exclusion criteria: (1) The maximum diameter of tumor is >2.0 cm by ultrasonography or perfusion CT, with obvious necrotic areas. The calcification area is >40% of the tumor's None of the rabbits revealed significant abdominal and surgical incision infection after the operation, and the incision was well-healed. All the tumors in groups B and C were eligible for inclusion criteria of the intrarenal VX2.
Changes in BF due to angiotensin II Tumor BF ( Fig. 2A) in groups B and C were significantly lower than the normal renal cortex BF in group A (P<0.001 and P<0.001, respectively; LSD-t). Tumor BF in group C (64.51 ± 21.01 ml/min/100 g) was lower than the tumor BF in group B (88.52 ± 24.25 ml/min/100 g), and the difference was not statistically significant (P=0.473, LSD-t). CAT BF in group C was significantly lower than the normal renal cortex BF in group A (P<0.001, LSD-t) and the CAT BF in group B (P<0.001, LSD-t). The CDT BF in group C was significantly lower than the normal renal cortex BF in group A (P<0.001, LSD-t) and the CDT BF in group B (P = 0.010, LSD-t). The RRC BF in group B was significantly greater than the RRC BF in groups A and C (P = 0.009 and P<0.001, respectively; LSD-t). BF in the PVM was unaffected by the tumor and the infusion of angiotensin II (P = 0.546, ANOVA).
Changes in BV due to angiotensin II
The tumor BV (Fig. 2B ) in groups B and C were significantly lower than the normal renal cortex BV in group A (P=0.001 and P<0.001, respectively; LSD-t). The BV of the tumor and CAT in group C (8.60 ± 8.60 ml/100 g and 20.01 ± 12.15 ml/100 g, respectively) were lower than the BF in group B (11.58 ± 6.53 ml/100 g and 29.15 ± 11.87 ml/100 g, respectively), and the difference was not statistically significant (P=0.516 and P=0.135, respectively, LSD-t). The BV in CAT, CDT, RRC and PVM were unaffected by the tumor and the infusion of angiotensin II (P = 0.248, P = 0.930, P = 0.774 and P = 0.675, respectively; ANOVA).
Fig. 2. Bar graphs of BF (A), BV (B), MTT (C) and PS (D). (A)
Tumor BF was significantly lower than the normal renal cortex. Angiotensin II significantly decreased the BF value of CAT, CDT and RRC, while the BF value of tumor tissues and PVM had no obvious changes. (B) Tumor BV were significantly lower than the normal renal cortex, and the BV value of tumor tissues, CAT, CDT, RRC and PVM had no obvious change after angiotensin II infusion. (C) Tumor MTT was longer than the normal renal cortex, and angiotensin II prolonged the MTT value of CAT, CDT, RRC and PVM, but there was no statistical significance. (D) Tumor PS were significantly lower than the normal renal cortex, and the PS value of tumor tissues, CAT, CDT, RRC and PVM had no obvious change by angiotensin II infusion. *P<0.05; **P<0.01. 
Changes in MTT due to angiotensin II
The difference in MTT (Fig. 2C) among tumors, CAT, CDT, RRC and PVM was not statistically significant (P = 0.190, P = 0.579, P = 0.171, P = 0.178 and P = 0.828, respectively; ANOVA). The MMT of tumors in group B (9.23 ± 6.45 seconds) was longer than that in group A (4.37 ± 2.31 seconds), but the difference was not statistically significant (P = 0.079, LSD-t). The MMT of tumors in group B (9.23 ± 6.45 seconds) was longer than that in group A (4.37 ± 2.31 seconds), but the difference was not statistically significant (P = 0.079, LSD-t). Compared with group B, angiotensin II prolonged the MTT of CDT and RRC (group C vs. group B; 6.59 ± 4.78 seconds vs. 3.56 ± 1.55 seconds, and 6.39 ± 3.85 second vs. 3.68 ± 3.12 seconds, respectively; ANOVA), but the difference was not statistically significant (P = 0.072 and P = 0.066, respectively; LSD-t).
Changes in PS due to angiotensin II
Tumor PS (Fig. 2D ) in groups B and C were significantly lower than the normal renal cortex PS in group A (P = 0.041 and P = 0.036, respectively; LSD-t), and the tumor PS was unaffected by the infusion of angiotensin II (P = 0.951, LSD-t). Furthermore, PS in CAT, CDT, RRC and PVM were unaffected by the tumor and the infusion of angiotensin II (P = 0.846, P = 0.423, P = 0.683 and P = 0.633, respectively; ANOVA).
Changes in RPS due to Angiotensin II
Tumor RPS (Fig. 3) in groups B and C were significantly greater than the normal renal cortex RPS in group A (P<0.001 and P<0.001, respectively; LSD-t). Furthermore, the tumor RPS increased from 83.23 ± 29.17% (group B) to 120.94 ± 31.84% (group C) by angiotensin II infusion (P = 0.007, LSD-t). Moreover, CAT RPS in group C was significantly higher than the normal renal cortex RPS in groups A and B (P<0.001 and P<0.001, respectively; LSD-t). Compared with group B, the RPS in CDT and RRC increased by angiotensin II infusion (P = 0.019 and P = 0.003, respectively; LSD-t). However, PVM RPS was unaffected by the tumor and the infusion of angiotensin II (P = 0.477, ANOVA).
Changes in perfusion parameters in CAT and CDT due to angiotensin II
There was no significant difference in perfusion parameters (BF, BV, MTT, PS and RPS) in group B between CAT and CDT (P = 0.053, P = 0.776, P = 0.510, P = 0.166 and P = 0.065, respectively; two-tailed student t-test) (Table 1) . Furthermore, perfusion parameters in group C between CAT and CDT were unaffected by the infusion of angiotensin II (P = 0.274, P = 0.225, P = 0.444, P = 0.395 and P = 0.183, respectively; two-tailed student's t-test) ( Table  1) . Fig. 3 . Bar graphs of RPS. The RPS value of tumor tissues and CAT were significantly higher than the normal renal cortex, and angiotensin II significantly increased the RPS value of tumor tissues, CAT, CDT and RRC. However, the RPS value of PVM had no obvious changes. *P<0.05; **P<0.01. 
Discussion
The typical microvasculature of normal organs and tissues has a hierarchical organization of arterioles, capillaries and venules. The composition of the microcirculation is specialized in concert with the unique functions of each organ and tissue [5] . Two sets of capillary network series combined with efferent arterioles is a feature of the renal vascular bed (Fig. 4A) . This structure is consistent with renal urinary function [11, [22] [23] [24] . Although the microvasculature of other organs and tissues also has its own specialized structure, these only have one set of capillary network (Fig. 4B) . The tumor vascular bed and preexisting vascular bed (maternal vascular bed) are parallel circuits [12, 25, 26] (Fig. 4C) .
As previously mentioned, tumor vascular abnormalities were present in morphology, structure and function, and there was a lack of autoregulation capability in the microcirculation of tumor tissues [9, 10, 27] . Furthermore, considerable studies have reported that normal tissues and organs have the ability to autoregulate BF. In particular, BF in the brain and kidney almost maintains stability within a certain range of blood pressure changes (80-160 mmHg) [22, 28] . A large number of clinical and experimental data has shown that angiotensin II can selectively enhance tumor vascular permeability and the BF of subcutaneous tissues, muscles, livers, and other tissues and organs [12] [13] [14] [15] [16] [17] 26] , such as the liver tumor shown in Fig. 5 . Glomerular filtration barriers include mechanical barriers and charge barriers, and the glomerulus has a selective filtration function. This has orifices within the range of 80-130 nm in diameter [22, 29, 30] . Renal tumor tissues lose its normal glomerular and renal tubular morphology. There was a significant difference between the normal renal cortex and renal cell carcinoma in all perfusion parameters (BF, BV, MTT and PS) in humans [31] . Compared with both sides of the normal renal cortex, it was also found that the BF, BV and PS values of rabbit renal VX2 tumors were significantly lower, and the RPS of renal tumor tissues were higher than that of normal renal cortex tissues in group B (normotension) (Fig. 6A ). These present results are consistent with the results of a literature [31] . Although angiotensin II did not change the capillary vascular permeability (PS) of intrarenal tumors and normal renal tissues, it improved the extravascular-intravascular fluid exchange capacity (RPS) of both tissues. Furthermore, the increase in normal renal tissue RPS caused the glomerular filtration rate (GFR), filtration fraction (FF) and urinary volume (UV) to simultaneously increase. The increase in tumor tissue RPS objectively reflects the abnormality of the tumor vasculature in morphology, structure and function (Fig. 6B) . The result of the present study is different from the results reported by literatures [13, 15, 16] .
The total area of the renal glomerular capillary was significantly larger than the total area of the tumor capillary. In terms of glomerular capillary permeability, the renal glomerular capillary network can be regarded as a large "tumor vascular bed". The smaller the renal tumor vascular bed at the early stage, and bigger the "tumor vascular bed" (maternal vascular bed), which are connected in parallel (Fig. 6B) . Angiotensin II constricts both afferent and efferent arterioles, but the constriction of efferent arterioles is greater than the constriction of afferent arterioles [11, 22, 23, 32, 33] . BF increased in the glomerular capillary, and BF and blood pressure decreased in peritubular capillaries [22] . After angiotensin II induced the high blood pressure, BF could enter into the tumor tissue, and enabled more BF to enter into the glomeruli (maternal vascular bed), which in turn reduced the BF of the intrarenal tumor. This is probably the reason why the BF, BV, PS and MTT of renal tumor tissues did not increase similar with the tumors in other organs, and why only the RPS of tumor tissues was significantly higher under angiotensin II-induced hypertension in the present study. In the maternal vascular bed, due to the constriction of the efferent arteriole, the MTT value was longer, and the BV and PS values did not exhibit any significant changes. Since perfusion pressure (PP), GFR, FF and UV were simultaneously increased by angiotensin II [23] , the extravascular-intravascular liquid exchange ratio in the glomerular capillary increased, the BF value became significantly lower, and the RPS value became significantly higher. To our , group B) , the RPS values of renal tumor tissues were significantly higher. The BF, BV and PS values were significantly lower than that in normal renal cortex tissues. (B) After angiotensin II administration (hypertension, group C), angiotensin II constricted the efferent arteriole more than the afferent arteriole. Then, angiotensin II simultaneously increased PP, GFR, FF and UV. The RPS value of normal renal cortex tissues (mother vascular bed) was significantly higher, the BF values were significantly lower, but the BV, PS and MTT values had no obvious changes, when compared with normal renal cortex tissues in group B. The RPS value of renal tumor tissues was significantly higher, while the BF, BV, PS and MTT values had no obvious changes, when compared with renal tumor tissues in group C. ↑↑, increase, P<0.01; ↓, decrease, P<0.05; ↓↓, decrease, P<0.01.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry knowledge, these findings have not been previously reported, in which perfusion CT was used to assess the hemodynamics changes of intrarenal tumors after angiotensin II-induced hypertension.
In the present, the discussion was limited to tumor tissues inside the kidney. As the tumor grew, it broke through the bondage of the renal fascia, and the extrarenal feeding artery joined the blood supply of the tumor tissue. This caused the tumor blood supply to multiply, instead of having only by renal artery. The effect of angiotensin II on the hemodynamics of tumors with multi-source feeding arteries will be discussed in future studies.
Conclusion
Perfusion CT can observe the influence of angiotensin II on normal renal tissues and intrarenal tumor BF distribution, to some extent, and the mechanism of angiotensin II in its effect on intrarenal tumor hemodynamics was elucidated. Angiotensin II induces more BF to enter the tumor tissue into the glomeruli, preventing the BF, BV, PS and MTT of renal tumor tissues from increasing similar to the tumors in other organs. However, no significant changes were found. Angiotensin II increased RPS in intrarenal tumors. Hence, RPS can objectively reflect the extravascular-intravascular fluid exchange capacity of capillaries, compared with PS.
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